Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Theoretical concerns: Because DSIP interacts with the opioid system and ACTH axis in animal models, chronic use could theoretically affect neuroendocrine regulation
In 2023, the US FDA designated BPC-157 as a Category 2 bulk drug substance, banning it from compounding pharmacies due to insufficient human safety data
How This Works 5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small molecule that selectively inhibits Nicotinamide N-methyltransferase (NNMT) [1]
Preclinical research has examined CJC-1295 No DAC (and related GHRH analogues) in models of skeletal muscle protein synthesis, lean mass accretion, adipose tissue lipolysis, bone mineral density, and collagen synthesis with IGF-1 elevation identified as the primary mediator of these downstream effects
